Author/Authors :
Garipagaoglu، نويسنده , , Melahat and Yalvac، نويسنده , , Serdar and Kose، نويسنده , , M.Faruk and Tulunay، نويسنده , , Gokhan and Kayikcioglu، نويسنده , , Fulya and اakmak، نويسنده , , Ahmet and Haberal، نويسنده , , Ali and Boran، نويسنده , , Nurettin and Adli، نويسنده , , Mustafa and Hayran، نويسنده , , Mutlu، نويسنده ,
Abstract :
Patients with inoperable carcinoma of the cervix treated with external plus high dose rate brachytherapy (HDRB), between 1988 and 1995 were evaluated retrospectively. According to stage, 5 year survival rates were 67.3% in stage IIb and 52.6% in stage III (P=0001) and disease free survival (DFS) rates were 54.0% in stage IIb and 43.9% in stage III (P=0.01). The following parameters were studied: age; stage; external beam dose; brachytherapy dose; total dose to point A; tumor mass; tumor response rate; bilateral or unilateral invasion of parametria in stage IIb; and bilateral or unilateral invasion of pelvic wall in stage IIIb; and the existence of hydronephrosis. The only significant parameter of 5 year survival and local control was tumor mass (P=0.003).
